Study of the central mechanism of electroacupuncture in improving pain in primary osteoporosis

注册号:

Registration number:

ITMCTR2024000345

最近更新日期:

Date of Last Refreshed on:

2024-09-01

注册时间:

Date of Registration:

2024-09-01

注册号状态:

Registration Status:

预注册

Prospective registration

注册题目:

电针改善原发性骨质疏松症疼痛的中枢机制研究

Public title:

Study of the central mechanism of electroacupuncture in improving pain in primary osteoporosis

注册题目简写:

English Acronym:

研究课题的正式科学名称:

电针改善原发性骨质疏松症疼痛的中枢机制研究

Scientific title:

Study of the central mechanism of electroacupuncture in improving pain in primary osteoporosis

研究课题的正式科学名称简写:

Scientific title acronym:

研究课题代号(代码):

Study subject ID:

SJCX24_0997

在二级注册机构或其它机构的注册号:

The registration number of the Partner Registry or other register:

申请注册联系人:

张迪

研究负责人:

徐道明

Applicant:

Zhang Di

Study leader:

Xu Daoming

申请注册联系人电话:

Applicant telephone:

15735212254

研究负责人电话:

Study leader's telephone:

13814019178

申请注册联系人传真 :

Applicant Fax:

研究负责人传真:

Study leader's fax:

申请注册联系人电子邮件:

Applicant E-mail:

1012056231@qq.com

研究负责人电子邮件:

Study leader's E-mail:

xudaoming@126.com

申请单位网址(自愿提供):

Study leader's website(voluntary supply):

研究负责人网址(自愿提供):

Study leader's website
(voluntary supply):

申请注册联系人通讯地址:

南京市鼓楼区南京中医药大学汉中门校区

研究负责人通讯地址:

江苏省南京市秦淮区汉中路155号

Applicant address:

Hanzhongmen Campus of Nanjing University of Traditional Chinese Medicine, Gulou District, Nanjing

Study leader's address:

No. 155, Hanzhong Road, Qinhuai District, Nanjing City, Jiangsu Province

申请注册联系人邮政编码:

Applicant postcode:

研究负责人邮政编码:

Study leader's postcode:

申请人所在单位:

江苏省中医院

Applicant's institution:

Jiangsu Provincial Hospital of Traditional Chinese Medicine

是否获伦理委员会批准:

Approved by ethic committee:

伦理委员会批件文号:

Approved No. of ethic committee:

2024NL-183-02

伦理委员会批件附件:

Approved file of Ethical Committee:

View

批准本研究的伦理委员会名称:

南京中医药大学附属医院(江苏省中医院)伦理委员会

Name of the ethic committee:

Ethics Committee of the Affiliated Hospital of Nanjing University of Traditional Chinese Medicine (Jiangsu Provincial Hospital of Traditional Chinese Medicine).

伦理委员会批准日期:

Date of approved by ethic committee:

2024/8/3 0:00:00

伦理委员会联系人:

王卯

Contact Name of the ethic committee:

Wang Mao

伦理委员会联系地址:

汉中路155号江苏省中医院五号楼404

Contact Address of the ethic committee:

No. 155 Hanzhong Road, No. 404, Building 5, Jiangsu Provincial Hospital of Traditional Chinese Medicine

伦理委员会联系人电话:

Contact phone of the ethic committee:

025-86560515

伦理委员会联系人邮箱:

Contact email of the ethic committee:

llwyhbgs@qq.com

研究实施负责(组长)单位:

江苏省中医院

Primary sponsor:

Jiangsu Provincial Hospital of Traditional Chinese Medicine

研究实施负责(组长)单位地址:

江苏省南京市秦淮区汉中路155号

Primary sponsor's address:

No. 155, Hanzhong Road, Qinhuai District, Nanjing City, Jiangsu Province

试验主办单位(项目批准或申办者):

Secondary sponsor:

国家:

中国

省(直辖市):

江苏省

市(区县):

南京市

Country:

China

Province:

Jiangsu Province

City:

Nanjing

单位(医院):

江苏省中医院

具体地址:

江苏省南京市秦淮区汉中路155号

Institution
hospital:

Jiangsu Provincial Hospital of Traditional Chinese Medicine

Address:

江苏省南京市秦淮区汉中路155号

经费或物资来源:

江苏省教育厅

Source(s) of funding:

Jiangsu Provincial Department of Education

研究疾病:

原发性骨质疏松症

研究疾病代码:

Target disease:

Primary osteoporosis

Target disease code:

研究类型:

Study type:

干预性研究

Interventional study

研究设计:

Study design:

随机平行对照

randomized controlled trial(parallel group design)

研究所处阶段:

Study phase:

探索性研究/预试验

Pilot clinical trial

研究目的:

本研究在观察电针干预原发性骨质疏松症(POP)疼痛临床疗效的基础上,应用rs-fMRI评价治疗前后自发性脑活动,探讨疼痛改善的中枢机制。在获得电针干预POP疼痛有效的影像学依据前提下,从而为临床提供电针治疗原发性骨质疏松症疼痛可供参考的治疗方案,丰富传统中医治疗骨质疏松症疼痛的治疗手段。

Objectives of Study:

In this study, on the basis of observing the clinical efficacy of electroacupuncture in the treatment of primary osteoporosis (POP) pain, rs-fMRI was used to evaluate spontaneous brain activity before and after treatment, and to explore the central mechanism of pain improvement. Under the premise of obtaining an effective imaging basis for electroacupuncture to intervene in POP pain, it is necessary to provide a reference treatment plan for the treatment of primary osteoporosis pain in clinical practice, and enrich the treatment methods of traditional Chinese medicine for osteoporosis pain.

药物成份或治疗方案详述:

治疗方案详述如下: 1.试验组:在基础防护(建议患者生活方式如补充营养、膳食均衡、增加日照时间、适当规律运动、避免吸烟及过量饮酒和补充足量钙等)的基础上,取穴双侧肝俞、肾俞、脾俞、阳陵泉、悬钟、足三里、委中,定位严格按照《中华人民共和国国家标准:穴位的命名和位置》(GB12346-90)。操作:皮肤常规消毒,将固定绝缘垫片粘贴在穴位上,患者取俯卧位,选用0.25mm×40mm一次性无菌针灸针。肝俞、脾俞与皮肤呈45°角向脊柱方向斜刺,针刺15mm,肾俞直刺25mm,足三里、悬钟、阳陵泉、委中均直刺25mm,进针后行捻转平补平泻法。双侧肝俞、肾俞4个穴位针柄连接XS-998B04型低频脉冲电针疗仪(南京医疗仪器研究所),予疏密波,频率为2 Hz/100Hz,30min后起针。隔日治疗1次,每周3次,共4周。 2.对照组:在基础防护(建议患者生活方式如补充营养、膳食均衡、增加日照时间、适当规律运动、避免吸烟及过量饮酒和补充足量钙等)的基础上,取穴同试验组,皮肤常规消毒,将固定绝缘垫片粘贴在穴位上,选用0.25mm×40mm安慰钝针,各穴位以同样手法将安慰钝针斜刺入泡沫垫片并到达绝缘胶层,患者有针头抵触感,但没有皮肤穿透。电针的波形、频率和电流强度同试验组,持续刺激30min后起针。隔日治疗1次,每周3次,共4周。对照组在研究结束给予4周电针补偿治疗。

Description for medicine or protocol of treatment in detail:

纳入标准:

①符合疾病诊断标准; ②有腰背疼痛表现,且VAS评分:3-7分; ③年龄在50岁-75岁; ④能够正确描述本人意愿,自愿填写知情同意书,同意参加临床试验者。

Inclusion criteria

(1) Meet the criteria for disease diagnosis; (2) Have low back pain and VAS score: 3-7 points; (3) Age 50-75 years old; (4) Those who can correctly describe their own wishes, voluntarily fill in the informed consent form, and agree to participate in clinical trials.

排除标准:

①有甲状腺功能亢进、类风湿关节炎、多发性骨髓瘤等继发性骨质疏松者; ②近3月内有新鲜椎体压缩性骨折; ③近6个月有抗骨质疏松药物服用史(双膦酸盐类、地舒单抗类、降钙素类等,钙尔奇不在抗骨质疏松症药物范围) ④伴有腰肌劳损、腰椎间盘突出、腰椎管狹窄、腰椎结核等其他腰部疾病的患者; ⑤有肾结石、带状疱疹等疾病或合并心血管、脑血管、肝、肾、造血系统等严重原发性疾病或全身多器官衰竭者 ⑥头动幅度大于2mm; ⑦存在fMRI检测禁忌者。

Exclusion criteria:

(1) Patients with secondary osteoporosis such as hyperthyroidism, rheumatoid arthritis, and multiple myeloma; (2) Fresh vertebral compression fracture in the past 3 months; (3) History of taking anti-osteoporotic drugs in the past 6 months (bisphosphonates, denosumabs, calcitonins, etc., calcineur is not in the scope of anti-osteoporosis drugs) (4) Patients with other lumbar diseases such as lumbar muscle strain, lumbar intervertebral disc herniation, lumbar spinal narrowness, lumbar tuberculosis, etc.; (5) Patients with kidney stones, herpes zoster and other diseases, or serious primary diseases such as cardiovascular, cerebrovascular, liver, kidney, hematopoietic system, or systemic multi-organ failure (6) The head movement amplitude is greater than 2mm; (7) Those who have contraindications to fMRI detection.

研究实施时间:

Study execute time:

From 2024-07-01

To      2025-06-30

征募观察对象时间:

Recruiting time:

From 2024-09-07

To      2025-02-28

干预措施:

Interventions:

组别:

试验组

样本量:

30

Group:

Experimental group

Sample size:

干预措施:

在基础防护的基础上,取穴双侧肝俞、肾俞、脾俞、阳陵泉、悬钟、足三里、委中。双侧肝俞、肾俞4个穴位针柄连接XS-998B04型低频脉冲电针疗仪,30min后起针。隔日治疗1次,每周3次,共4周。

干预措施代码:

Intervention:

On the basis of basic protection, take acupoints on both sides of the liver, kidney, spleen, Yanglingquan, Hanging Bell, Zusanli, and Weizhong. The four acupuncture points of Liver Yu and Kidney Yu on both sides are connected to the XS-998B04 low-frequency pulse electroacupuncture device, and the needle is started after 30min. Treatment once every other day, 3 times a week for 4 weeks.

Intervention code:

组别:

对照组

样本量:

30

Group:

Control group

Sample size:

干预措施:

在基础防护的基础上,取穴同试验组,使用假电针治疗。电针的波形、频率、电流强度、治疗时间、周期同试验组。

干预措施代码:

Intervention:

On the basis of basic protection, the acupoints were taken from the same experimental group and treated with sham electroacupuncture. The waveform, frequency, current intensity, treatment time and cycle of electroacupuncture were the same as those of the experimental group.

Intervention code:

样本总量 Total sample size : 60

研究实施地点:

Countries of recruitment
and research settings:

国家:

中国

省(直辖市):

江苏省

市(区县):

南京市

Country:

China

Province:

Jiangsu Province

City:

Nanjing

单位(医院):

江苏省中医院

单位级别:

三级甲等

Institution/hospital:

Jiangsu Provincial Hospital of Traditional Chinese Medicine

Level of the institution:

Class 3A

测量指标:

Outcomes:

指标中文名:

rs-fMRI数据采集

指标类型:

次要指标

Outcome:

rs-fMRI data acquisition

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

Oswestry功能障碍指数

指标类型:

次要指标

Outcome:

OswestryDisabilityIndex,ODI

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

腰椎关节活动度

指标类型:

次要指标

Outcome:

Lumbar range of motion

Type:

Secondary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

指标中文名:

视觉模拟评分法

指标类型:

主要指标

Outcome:

visual analogue scale,VAS

Type:

Primary indicator

测量时间点:

测量方法:

Measure time point of outcome:

Measure method:

采集人体标本:

Collecting sample(s)
from participants:

标本中文名:

组织:

Sample Name:

none

Tissue:

人体标本去向

使用后销毁

说明

Fate of sample 

Destruction after use

Note:

征募研究对象情况:

尚未开始

Not yet recruiting

年龄范围:

最小 50
Min age years
最大 75
Max age years

Recruiting status:

Participant age:

性别:

Gender:

男女均可

Both

随机方法(请说明由何人用什么方法产生随机序列):

应用SPSS 23.0软件生成随机数进行随机分组,将入组60名患者随机分为针刺组和假针刺组

Randomization Procedure (please state who generates the random number sequence and by what method):

SPSS 23.0 software was used to generate random numbers for randomization, and 60 patients were randomly divided into acupuncture group and sham acupuncture group

盲法:

Blinding:

是否共享原始数据:

IPD sharing:

Yes

共享原始数据的方式(说明:请填入公开原始数据日期和方式,如采用网络平台,需填该网络平台名称和网址):

临床试验数据管理平台

The way of sharing IPD”(include metadata and protocol, If use web-based public database, please provide the url):

http://www.medresman.org

数据采集和管理(说明:数据采集和管理由两部分组成,一为病例记录表(Case Record Form, CRF),二为电子采集和管理系统(Electronic Data Capture, EDC),如ResMan即为一种基于互联网的EDC:

1. 建立数据库。 2. 数值范围和逻辑检查,如有疑问,填写疑问清单(query list),由研究者对疑问清单中的问题进行解答。完成数据核查报告后,锁定数据库。 3. 应保存质量控制的有关文件,如数据一致性检查、数值范围和逻辑检查的原始记录、盲态审核时的原始记录、研究者之间交流的疑问记录等。

Data collection and Management (A standard data collection and management system include a CRF and an electronic data capture:

1. Build a database. 2. Numerical range and logic check, if in doubt, fill in the query list, and the researcher will answer the questions in the question list. After completing the data verification report, lock the database. 3. Relevant documents for quality control should be kept, such as the original records of data consistency checks, numerical range and logic checks, original records of blind audits, and records of doubts exchanged between investigators.

数据管理委员会:

Data Managemen Committee:

暂未确定

Not yet

研究计划书或研究结果报告发表信息
(杂志名称、期、卷、页,时间;或网址):

Publication information of the protocol/research results report
(name of the journal, volume, issue, pages, time; or website):

ITMCTR BJ-ICP:07032215-5 Tip: IE8 is recommended Use the system with widescreen display resolution above